SEC Form 4 · accession 0001477932-15-006347
Nascent Biotech Inc. · NBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Lowell Thomas Holden
Officer — CFO · Director
Period of report
Sep 4, 2015
Accepted (ET)
Oct 13, 2015 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2015 | P | 617,346 | $1.45 | A | 717,346 | D |
Table II — derivative securities
No Table II lines on this filing.